A cure for cancer to now looking at helping inflammatory just does not wet my appetite.
Looking for partners/licence for inflammation might help but it is starting to sound desperate.
Raise some money and get dx-3 back to clinic, if it’s a success it doesn’t matter how many shares are out there(that only matters if it’s a failure and then we are done anyway)
Changing the narrative of DX uses is like a gold miner now looking for lithium because they failed at one and are jumping on to another that brings on new investors and sentiment
If they can find some cash with inflammation then all good, but if they don’t restart dx-3 to aim to clinic for Cancer cures then Cancer has been put in the bin and what we all invested in now lies on new narratives
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)